Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions. The drug fosdenopterin/rcPMP ...
A metric that looks beyond height and weight to underlying biological markers of metabolic health is providing revised estimates of disease risk. According to a new study led by scientists at the ...
A significant overlap has been identified in the functionalities of genes associated with immune and metabolic disorders, suggesting a fundamental frameshift is needed in our understanding of the two.
In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...
Studies used in comparison of cyclic pyranopterin monophosphate-treated versus untreated patients with MoCD Type A. Credit: Journal of Inherited Metabolic Disease (2025). DOI: 10.1002/jimd.70000 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results